Gathering information have recommended seizures happen often in patients with neuronal surface antibody‐mediated immune system encephalitis. We meant to assess seizure results and potential components related with the advancement of epilepsy in patients with anti‐N‐methyl‐D‐aspartate receptor (NMDAR), anti‐leucine‐rich glioma‐inactivated 1 (LGI1), and anti‐gamma‐aminobutyric‐acid B receptor (GABABR) encephalitis. Patients with anti‐NMDAR, anti‐LGI1, and anti‐GABABR encephalitis were tentatively selected from 2014 to June 2019, with a middle follow‐up time of 30.5 months (range 8–67 months). Seizure results were surveyed and hazard variables of epilepsy were examined. An aggregate of 119 patients with anti‐NMDAR, anti‐LGI1, and anti‐GABABR encephalitis were incorporated, and 83 (69.7%) of them created new‐onset seizures. As a result it was observed that, before the finish of follow‐up, 17 (21.3%) of 80 patients had seizure backslides after discontinuous seizure abatement or displayed uncontrolled seizure scenes, adding to epilepsy.
Reference link- https://onlinelibrary.wiley.com/doi/10.1002/acn3.51137
